B7-H4 protein in tumor vaccine for glioma
Part of Cancer clinical trials.
This study looks at a protein called B7-H4 to help create a potential vaccine for glioma (a type of brain tumor). It uses a small tissue sample taken during your surgery to check if the vaccine might work for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a glioma (a brain tumor) that needs surgery.
- You are between 18 and 80 years old.
- A small piece of your tumor (about the size of a pea) can be used for research without affecting your diagnosis.
- You are not currently in another clinical trial.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a tumor vaccine made from your own surgery tissue can help treat solid tumors, specifically gliomas (brain tumors). It is open to patients having brain surgery at Huashan Hospital, including those with non-tumor conditions like stroke or injury, as long as enough tissue is available.
This trial tests a personalized vaccine created by AI to target your specific brain tumor. It is for people with a glioma that came back after standard treatments like surgery, radiation, or chemotherapy, and whose tumor has enough genetic mutations to make the vaccine.
This trial tests a combination of several drugs and a vaccine to see if they can help treat glioma that has not gone away with previous treatment. It is for people whose tumors have certain gene changes and who still have some tumor remaining after standard therapy.
This trial tests a new cell therapy (QH104) for people with an aggressive brain tumor called high-grade glioma that has come back or worsened after standard treatment. The therapy targets a specific protein (B7-H3) on tumor cells to try to fight the cancer.
This trial is testing a new vaccine (Bvax) added to the usual chemotherapy and radiation for glioblastoma. It aims to train your immune system to fight the tumor and possibly improve outcomes.
This early-stage study tests a personalized cancer vaccine designed to prevent glioblastoma (a serious brain tumor) from coming back after surgery and standard treatment. The vaccine aims to train your immune system to recognize and attack any remaining cancer cells.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.